This inventor holds 4 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1980-1981.
Location History:
- Both of Bad Soden am Taunus, DE (1980)
- Bad Soden am Taunus, DE (1980 - 1981)
- Bad Soden am Taunis, DE (1981)
Company Filing History:
Years Active: 1980-1981
Title: Irmgard Hoffmann: A Pioneer in Medicinal Chemistry
Introduction
Irmgard Hoffmann is a distinguished inventor based in Bad Soden am Taunus, Germany. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with anxiolytic properties. With a total of 4 patents to her name, Hoffmann's work has had a profound impact on the pharmaceutical industry.
Latest Patents
Hoffmann's latest patents include innovative compounds such as 8-Aryl-5,6,7,8-tetrahydropyrazolo(3,4-B)(1,4)-diazepine-1H and 4-Aryl-5,6,7,8-tetrahydropyrazolo(3,4-B)-(1,5)diazepine-1H,4H-5,7-diones. These compounds are characterized by their complex chemical structures, which include various substituents that enhance their medicinal properties. The formulations are designed to provide anxiolytic effects, making them valuable in the treatment of anxiety disorders.
Career Highlights
Hoffmann has been associated with Hoechst Aktiengesellschaft, a leading company in the pharmaceutical sector. Her work has not only advanced the understanding of medicinal compounds but has also contributed to the development of effective treatments for mental health conditions.
Collaborations
Throughout her career, Hoffmann has collaborated with notable colleagues such as Karl Schmitt and Gerhard Rackur. These partnerships have fostered a collaborative environment that has led to innovative breakthroughs in medicinal chemistry.
Conclusion
Irmgard Hoffmann's contributions to the field of medicinal chemistry are noteworthy and continue to influence the development of new therapeutic agents. Her innovative spirit and dedication to research exemplify the role of inventors in advancing healthcare solutions.